Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Boreo, L. Petecchia, F. Sabatini, M. Silvestri, G. Rossi (Genoa, Italy). Effects of the PDE4 inhibitor roflumilast n-oxide on the adherence of polymorphonuclear cells (PMNC) to bronchial epithelial cells (BEAS-2B) induced by non-typeable Haemophilus influenzae. Eur Respir J 2009; 34: Suppl. 53, 422

Member's Comments

SABATINI Federica - 12.09.2009 12:57
da una amica solidale!!!!
In BOCCA AL LUPO!!!!!!!!!!!

Related content which might interest you: Effect of roflumilast N-oxide on non-typable haemophilus influenzae (NTHi) interaction with human airway epithelial A549 cells Source: Annual Congress 2011 - Epithelial cell biology Year: 2011 Roflumilast N-oxide (RNO) decreases neutrophil adhesion to human bronchial epithelial cells (BEAS-2B) induced by cigarette smoke condensate (CSC) in vitro Source: Annual Congress 2010 - Emerging mechanisms in lung injury Year: 2010 Roflumilast N-oxide (RNO) alleviates from RSV-induced loss of ciliated cells and enhanced MUC5AC in differentiated human bronchial epithelial cells (D-HBE) Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010 Exposure of a bronchial epithelial cell line (BEAS-2B) to haemophilus influenzae (NTHi) lysate increases TLR-2 and TNF-α synthesis and results in an enhanced PMN adherence to epithelial cells Source: Annual Congress 2008 - Airway infection and host defence Year: 2008 Modulation of TNFα-induced ICAM-1 expression in a human bronchial epithelial cell line (Beas-2B) by roflumilast N-oxide (RNO), salmeterol (Sal) and budesonide (Bud) Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II Year: 2007 Effect of clarithromycin on rhinovirus-16 infection in A549 cells Source: Eur Respir J 2006; 27: 12-19 Year: 2006 Effects of PDE4 inhibitors on eotaxin-3 (CCL26) expression in lung epithelial cells Source: Annual Congress 2009 - Epithelial cell biology Year: 2009 Attenuating effect of tiotropium bromide on IL-8 production from human bronchial epithelial cells, BEAS-2B in vitro Source: Annual Congress 2009 - Epithelial cell biology Year: 2009 Effects of IL-4 and neutrophil defensins (HNP1-3) on differentiation of primary bronchial epithelial cells (PBEC) Source: Annual Congress 2007 - Epithelial networks in the airways Year: 2007 The PDE4 inhibitor roflumilast N-oxide partly restored cigarette smoke (CS)-induced tight junction disassembly in human airway epithelial cells (Calu-3) – role of MAPK Source: Annual Congress 2008 - Basic science in asthma and COPD II Year: 2008 In vitro modulation of the cytokine-induced human bronchial epithelial cell (HBEC) functions by ciclesonide (CIC) Source: Eur Respir J 2004; 24: Suppl. 48, 346s Year: 2004 Secretory leukoprotease inhibitor (SLPI) is removed from media of primary bronchial epithelial cells (PBEC) in the presence of neutrophil elastase (NE) Source: Eur Respir J 2005; 26: Suppl. 49, 554s Year: 2005 Effect of phosphodiesterase IV inhibitors on eotaxin expression in bronchial epithelial cells – Comparison between immortalized and primary line Source: Annual Congress 2011 - Lung cell biology Year: 2011 Cytokine-induced production of eotaxin-3 by human lung epithelial cells is inhibited by levocetirizine Source: Eur Respir J 2005; 26: Suppl. 49, 98s Year: 2005 The PDE4 inhibitor roflumilast N-oxide partly reversed TGFß1-induced changes in collagen I and E-cadherin expression in human airway epithelial cells Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD Year: 2008 Inhibitory activity of fluticasone propionate (FP), on the constitutive or cytokine-induced bronchial epithelial cell (HBECs) functions in vitro Source: Eur Respir J 2003; 22: Suppl. 45, 76s Year: 2003 Protective effect of MAPK inhibitors and budesonide against apoptosis induced by TGF-β in primary cultures of human bronchial epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 394s Year: 2003 Resveratrol impairs cytokine release from human airway smooth muscle cells (HASMCs) and alveolar macrophages (AM) in COPD Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009 Reduction of rhinovirus 16-induced epithelial ICAM-1 expression by cilomilast (Ariflo) Source: Eur Respir J 2003; 22: Suppl. 45, 395s Year: 2003 Proteasome inhibitors modulate chemokine production in lung epithelial and monocytic cells Source: Eur Respir J 2004; 24: 40-48 Year: 2004